Collaborative CDA Template Review Process Pilot

Description

This pilot project will explore using a collaborative review process, performed by resources from across a small set of domain workgroups, to facilitate collaboration CDA template assessment. The selected resources also will be engaged in working on development of the corresponding FHIR resources. The objective is to understand what is involved in working across workgroups to facilitate collaboration on CDA template assessment.

The project is investigative, in that it intends to investigate and document the identified changes needed to align and harmonize the templates, but it does not include doing the work to address the changes.

Once the agreed upon list of changes has been identified, a separate project or projects will be initiated to address making the needed changes. This will be handled as a two-step process and this project covers the first step only. In the future, this type of work could incorporate collaboration across other work groups such as Patient Administration, PHER, due to their expertise with templates such as record target and immunization activity.

This project will explore a cross-workgroup collaboration model that establishes a way to perform detailed review of CDA templates in order to identify issues and document change requirements that will improve and inform the creation of CDA templates and align them with ongoing FHIR resource development work.

The following CDA R2.0Templates and value sets are in scope for piloting this the collaborative review process:

1. For PC:

- C-CDA R2.1 Problem Concern Entry and all encompassed templates/value sets

- IPS Problem Concern Entry and all encompassed templates/value sets

- C-CDA R2.1 Allergy-Intolerance Concern Entry and all encompassed templates/value sets

- IPS Allergy and Intolerance Concern and all encompassed templates/value sets.

2. For FM:

- C-CDA R2.1 Coverage Activity Entry

- C-CDA R2.1 Planned Coverage

- C-CDA R2.1 Policy Activity Entry

3. For Pharmacy:

- C-CDA R2.1 Medication Activity Entry

- C-CDA R2.1 Planned Medication Activity

- IPS Medication Statement

- Pharmacy UV Medication Statement

- Pharmacy UV Medication Order

Misc Notes
The focus will include both US Realm and international perspectives, but the focus will be on analyzing the C-CDA R2.1 templates in scope for the project. For example, analysis of the C-CDA R2.1 Medication Activity template may include assessment of its alignment with UV realm templates designed for the same purpose. Clarifications about the expected relationship between UV and realm-specific templates could be included in the paper.